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ABSTRACT 
Extended spectrum beta-lactamases (ESBLs) are defined as enzymes produced by certain 
bacteria that are able to hydrolyze extended spectrum cephalosporin. They are therefore 
effective against beta-lactam antibiotics such as ceftazidime, ceftriaxone, cefotaxime and 
oxyimino-monobactam. The objective of the current review is to provide a better 
understanding of ESBL and the epidemiology of ESBL producing organisms which are 
among those responsible for antibiotic resistant strains. Globally, ESBLs are considered to be 
problematic, particularly in hospitalized patients. There is an increasing frequency of ESBL 
in different parts of the world. The high risk patients are those contaminated with ESBL 
producer strains as it renders treatment to be ineffective in these patients. Thus, there an 
immediate needs to identify EBSL and formulate strategic policy initiatives to reduce their 
prevalence. 
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